But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

“Asthma is caused by a deviated immune response ... contact your physician to see if another maintenance therapy can help.

The European Commission has followed the lead of the US FDA and approved AstraZeneca's Tezspire as an add-on maintenance therapy for patients with severe asthma, becoming the first and only ...

The final appraisal document for Dupixent (dupilumab) has given the green light to use of the drug as an add-on maintenance therapy for people aged over 12 with severe asthma characterised by type ...

GSK (GSK) announced that the China National Medical Products Administration has approved Nucala, a monoclonal antibody that ...

You may have recently heard about SMART (Single Maintenance and Reliever Therapy). It’s a somewhat new approach to asthma management that combines the use of a single inhaler for both ...

Bronchodilators SABA & SAMA. Used Primarily for Rescue in Asthma but may be Used for Control/Maintenance in COPD: Inhaled SABA are the most widely used treatment for acute relief of asthma and ...

Although it is recognized that airway inflammation is key to asthma pathogenesis, the marked heterogeneity in its clinical course and variations in response to treatment make it a challenging ...

China approves GSK's Nucala for chronic rhinosinusitis with nasal polyps, adding to its existing uses in asthma and other ...

First new treatment for asthma attacks in 50 years hailed as 'game-changer' Doctors and patients have hailed a new treatment for serious asthma and chronic obstructive pulmonary disease (COPD ...

Tools You Can Use to Control Winter Asthma, Allergy Symptoms WEDNESDAY, Dec. 18, 2024 (HealthDay News) -- Winter is here, and that can make it difficult for those with asthma to control their ...